CRISPR gene-editing restores vision in patients with rare eye disease
Researchers from the Casey Eye Institute at the Oregon Health & Science University are reporting the successful use of CRISPR gene-editing to restore vision for patients with a rare eye disease. Leber congenital amaurosis, or LCA, is an uncommon genetic form of vision impairment, but seven Read More...